The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Tackling NAFLD: Three Targeted Populations
Hepatology. 2020 Aug 31. doi: 10.1002/hep.31533. Online ahead of print.
Kara Wegermann1, Ayako Suzuki12, Alisha M Mavis3, Manal F Abdelmalek1, Anna Mae Diehl1, Cynthia A Moylan12
Author information
1Division of Gastroenterology, Department of Medicine, Duke University Health System, Durham, NC, USA.
2Department of Medicine, Durham Veterans Affairs Medical Center, Durham, NC, USA.
3Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Duke University Health System, Durham, NC, USA.
Abstract
The scale of the non-alcoholic fatty liver disease (NAFLD) epidemic is staggering. It is estimated that 24 percent of the world's people have NAFLD [1]. By the year 2030, the United States will have approximately 100 million individuals with NAFLD, leading to a higher incidence of decompensated cirrhosis, hepatocellular carcinoma (HCC), and liver-related death [2]. NAFLD is strongly associated with the metabolic syndrome and its individual components [3]. Unfortunately, relative to the scale of the epidemic, few public health dollars are spent on obesity and NAFLD prevention [4].